Michael Christel

How one biotech is tackling the unmet need for additional immunotherapies and combination approaches in cancer.

It's no secret that there is increased clinical focus now on the prevention and early detection of Alzheimer's.

With the public release of physician payment data slated for September, the implications for medical and scientific communications are many.

The potential of comparative effective research in transforming healthcare remains untapped, but the opportunities are there.

We got the chance to speak with Nancy Dreyer, chief of scientific affairs and senior VP at Quintiles Outcome about the current tide for comparative effectiveness research